30 March 2022 in Scientific Reports
Although the main route of infection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the respiratory tract, liver injury is also commonly seen in many patients, as evidenced by deranged parenchymal liver enzymes. Furthermore, the severity of liver damage has been shown to correlate with higher mortality. Overall, the mechanism behind the liver injury remains unclear. We showed in this study that intra-hepatic bile duct cells could be grown using a human liver organoid platform. The cholangiocytes were not only susceptible to SARS-CoV-2 infection, they also supported efficient viral replication. We also showed that SARS-CoV-2 replication was much higher than SARS-CoV. Our findings suggested direct cytopathic viral damage being a mechanism for SARS-CoV-2 liver injury.
7 March 2022 in Immunology
The conditions and extent of cross-protective immunity between SARS-CoV-2 and common-cold human coronaviruses HCoVs remain open despite several reports of pre-existing T cell immunity to SARS-CoV-2 in individuals without prior exposure. Using a pool of functionally evaluated SARS-CoV-2 peptides, we report a map of 126 immunogenic peptides with high similarity to 285 MHC-presented peptides from at least one HCoV. Employing this map of SARS-CoV-2-non-homologous and homologous immunogenic peptides, we observe several immunogenic peptides with high similarity to human proteins, some of which have been reported to have elevated expression in severe COVID-19 patients. After combining our map with SARS-CoV-2-specific TCR repertoire data from COVID-19 patients and healthy controls, we show that public repertoires for the majority of convalescent patients are dominated by TCRs cognate to non-homologous SARS-CoV-2 peptides. We find that for a subset of patients, >50% of their public SARS-CoV-2-specific repertoires consist of TCRs cognate to homologous SARS-CoV-2-HCoV peptides. Further analysis suggests that this skewed distribution of TCRs cognate to homologous or non-homologous peptides in COVID-19 patients is likely to be HLA-dependent. Finally, we provide 10 SARS-CoV-2 peptides with known cognate TCRs that are conserved across multiple coronaviruses and are predicted to be recognised by a high proportion of the global population. These findings may have important implications for COVID-19 heterogeneity, vaccine-induced immune responses, and robustness of immunity to SARS-CoV-2 and its variants.
8 September 2026 in British Journal of Dermatology
Background: T cells are often enriched at barrier tissues, yet little is known about their roles in barrier sensing and relevance to associated disease. CD1a is a major histocompatibility complex class I-like molecule expressed by Langerhans cells, and forms complexes with lipid antigens to facilitate recognition by nonclassical CD1a-reactive T cells. Objectives: To investigate the role of CD1a in the disease pathogenesis of atopic dermatitis (AD). Methods: Human skin challenge, single-cell and spatial transcriptomic-based approaches and functional immunology were used to assess the role of CD1a in AD pathogenesis. Results: Skin allergen challenge in individuals with AD induced skin CCL17 and CCL22 concentrations that promoted CCR4+ T-cell migration. Single-cell resolution proteo-transcriptomics from human lesional AD skin tissue identified a dominant CCL17/CCL22 source as a persistent population of activated skin CD1a+ dendritic cells (DCs) previously shown to be transiently enriched in human skin wounds. Single-cell resolution spatial tissue analyses showed that these cells were predominantly located within lesional subepidermal microcompartment clusters co-localizing with distinct subpopulations of T helper 2 (Th2) cells. Activated skin DCs expressed neutral sphingomyelinase, which processed inhibitory long-chain sphingomyelin to drive Th2 cell CD1a autoreactivity. Conclusions: The findings are consistent with human CD1a-autoreactive T cells sensing chronic skin barrier compromise through the detection of altered sphingomyelin cycle activity, with implications for the pathogenesis of atopic and related disease.
12 February 2021 in medRxiv
Background Although the main route of infection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the respiratory tract, liver injury is also commonly seen in many patients, as evidenced by deranged parenchymal liver enzymes. Furthermore, patients with severe liver disease have been shown to have higher mortality. Overall, the mechanism behind the liver injury remains unclear. Approach and results We showed that intra-hepatic bile duct cells could be grown using a human liver organoid platform. The cholangiocytes were not only susceptible to SARS-CoV-2 infection, they also supported efficient viral replication. We also showed that SARS-CoV-2 replication was much higher than SARS-CoV. Conclusion Our findings suggested direct cytopathic viral damage being a mechanism for SARS-CoV-2 liver injury.